Xconomy National

Archives

by in

Entry	Author	Date	Location
FDA vs. Drug Ads: Cut the Kids and Dogs, Spell Out Side Effects	Arlene Weintraub	02/06/12	National
Affymax Prepares to Mount Challenge to Amgen Anemia Drug Monopoly	Luke Timmerman	01/25/12	San Francisco
Onyx, Bayer’s Next Cancer Drug Shows Slim Survival Edge	Luke Timmerman	01/17/12	San Francisco
Five Myths You’ll Hear This Week at the JP Morgan Healthcare Conference	Luke Timmerman	01/09/12	National
Alnylam Gets First Hint of Effectiveness for RNAi Cholesterol-Lowering Drug	Luke Timmerman	01/04/12	Boston
Momenta, Baxter Team Up on Biosimilars	Erin Kutz	12/23/11	Boston
Millennium, Metamark, Amgen, & More Boston Life Sciences Headlines	Erin Kutz	12/23/11	Boston
The Year in Seattle Biotech: Lots of Acquisitions, Few New Startups	Luke Timmerman	12/22/11	Seattle
MIT-Born Enumeral Advances Human-Based Method for Hunting Drugs	Arlene Weintraub	12/20/11	New York
Amgen, Watson Strike $400M Deal for Biosimilar Cancer Drugs	Luke Timmerman	12/19/11	National
Amgen CEO Kevin Sharer’s Report Card: C	Luke Timmerman	12/19/11	National
Affymax Passes FDA Panel Scrutiny, Looks to Challenge Amgen Anemia Drug	Luke Timmerman	12/07/11	San Francisco
Affymax Shares Climb As FDA Considers Wider Use for Anemia Drug	Luke Timmerman	12/05/11	San Francisco
My Immunex Remembrance: Getting Scooped on the Biggest Biotech Story of 2001	Luke Timmerman	11/18/11	Seattle
Affymax Gears Up for its Make-or-Break Moment, As Anemia Drug Faces FDA Scrutiny	Luke Timmerman	11/17/11	San Francisco
Biopharmaceuticals: Nothing Compares to You	Stewart Lyman	11/17/11	National
The Immunex Impact: A Trivia Quiz	Luke Timmerman	11/15/11	Seattle
Editor’s Picks: Xconomy Boston’s Top 20 Stories of the Third Quarter	Gregory T. Huang	10/28/11	Boston
Amgen Cuts 70 Washington Jobs, Hutch Spins Off Blaze Bioscience, Henney Enters the Hall, & More Seattle-Area Life Sciences News	Luke Timmerman	10/20/11	Seattle
Amgen Confirms 380 Layoffs in R&D; Cuts Coming to Seattle, SF, Boston	Luke Timmerman	10/19/11	National
Got Some Immunex Memorabilia in the Closet? Break it Out at the Immunex Impact Dec. 1	Luke Timmerman	10/19/11	Seattle
NextBio Sees Growth in Next Market: Physicians Seeking Help Interpreting Individual Genomes	Luke Timmerman	10/18/11	San Francisco
Amgen Mulls R&D Cuts, Thong Le Named WBBA Chairman, NanoString’s Version 2.0, & More Seattle-Area Life Sciences News	Luke Timmerman	10/13/11	Seattle
Amgen Looking to Improve Focus and “Re-allocate Resources” for R&D, Say More Oct. 24	Luke Timmerman	10/12/11	National
Merck Fine-Tunes Biosimilars Strategy as FDA Guidelines Loom	Arlene Weintraub	10/05/11	New York
Crescendo Bioscience Nabs $56M to Help Personalize Rheumatoid Arthritis Therapy	Luke Timmerman	09/08/11	San Francisco
Fearless Fantasy Football, Uh, I Mean Biotech, Predictions for the Season Ahead	Luke Timmerman	09/06/11	National
Jennerex Shows that Unorthodox Cancer-Fighting Virus Can be Delivered the Usual Way	Luke Timmerman	08/31/11	San Francisco
Zymeworks Snags $187M Deal With Merck to Discover Multi-Pronged Antibodies	Luke Timmerman	08/29/11	Seattle
Acceleron, Celgene Take Aim at Amgen’s Multibillion-Dollar Anemia Market	Luke Timmerman	08/05/11	Boston
Page 1 of 9	next page »